Summer Institute in Pharmacoepidemiology and Outcomes in Rhode Island, USA

The University of Rhode Island College of Pharmacy will hold the second annual Summer Institute in Pharmacoepidemiology on June 9-11, 2008 at the Whispering Pines Conference Center of the Alton Jones Campus of the University of Rhode Island in West Greenwich, Rhode Island.

The Summer Institute in Pharmacoepidemiology was conceived to provide a forum for the continued acquisition of information and methods in pharmacoepidemiology, and the exchange of ideas between government, academia and industry. It is targeted at the many professionals and students planning careers in drug safety, development of practice guidelines, drug policy and clinical trials.

Pharmacoepidemiology is a relatively new (2-3 decades) application of epidemiology, and the only branch of epidemiology that is directed entirely at health issues arising from therapies intended to treat or prevent disease. Medications are prescribed to improve the health of patients, but all medications are accompanied by some level of risk. When medications are used inappropriately, or when the level of risk is not well understood, medication use can lead to a decline, rather than an improvement in health.

The University of Rhode Island College of Pharmacy Summer Institute in Pharmacoepidemiology is the first of its kind to begin to address the higher level training needs of professionals finding themselves responsible for surveillance, pharmacovigilance, formulary development, practice guidelines, risk management and related activities in government and industry.

Five courses, 3.5 hours each, will take place over a three day period. Meal times will permit faculty and students to continue discussions, exchange information, and identify topics for future research. Courses and faculty are described below.

Pharmaceutical Outcomes Research,
Diana Brixner, PhD/ Joanne LaFleur, PharmD, MPH
University of Utah

Individualized Medicine,
Sean P. David, MD, SM, DPhil,
Brown University

Systematic Literature review and Meta-analysis,
Susan D. Ross, MD, FRCPC
Consultant in Evidence Based Medicine

Drug Safety Surveillance at FDA ,
Judy A. Staffa, PhD, RPh,
CDER/FDA

Therapeutical Risk Management: Pharmaceutical Industry Practice
Songlin Xue, MD, PhD,
Novartis Pharmaceuticals

Tuition for the entire three days is $925 and includes all five courses with our nationally recognized faculty, all course materials, and lunches for each of the three days, June 9, 10 and 11, 2008.

Register online at: www.uri.edu/pharmacy/ce/si08.

Accomodations at the Alton Jones are $360 for single occupancy and $240/person for double occupancy.

For reservations, download form at: www.uri.edu/pharmacy/ce/si08/room_reservation_form.pdf or telephone (401) 397-3361, ext. 6056.

Accomodation fees include dinner on Monday and Tuesday evening, June 9 and 10, 2008, and breakfasts on Tuesday, and Wednesday, June 10 and 11, 2008. Lunches are included in course registration fee. Payment is NON-REFUNDABLE after May 8, 2008 Reservations will be honored in the order in which they are received.

For more information see our website: www.uri.edu/pharmacy/ce/si08

Diana Brixner, RPh, PhD
Associate Professor and Chair
Department of Pharmacotherapy
Executive Director Outcomes Research Center
President International Society of Pharmacoeconomics and Outcomes Research (ISPOR)